• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磨牙后三角区鳞状细胞癌:治疗结果

Squamous cell carcinoma of the retromolar trigone: Treatment outcomes.

作者信息

Nishi Hideaki, Shinozaki Takeshi, Tomioka Toshifumi, Maruo Takashi, Hayashi Ryuichi

机构信息

Department of Otolaryngology, Sasebo City General Hospital, 9-3 Hirasemachi, Sasebo, Nagasaki, 857-8511, Japan; Department of Head and Neck Surgery, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.

Department of Head and Neck Surgery, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.

出版信息

Auris Nasus Larynx. 2018 Apr;45(2):337-342. doi: 10.1016/j.anl.2017.05.011. Epub 2017 Jun 16.

DOI:10.1016/j.anl.2017.05.011
PMID:28624429
Abstract

OBJECTIVE

Squamous cell carcinoma (SCC) of the retromolar trigone is uncommon, accounting for 1.4% of all oral cancer cases in Japan. Few studies have examined the optimal treatment for this cancer. The aim of this study was to evaluate the outcome of treatment for primary SCC of the retromolar area.

METHODS

We retrospectively analyzed the outcome and prognosis of 45 patients (38 men, 7 women) with SCC of the retromolar trigone who underwent treatment in our department between July 1992 and March 2011.

RESULTS

Mean age was 62.4 years. Clinical stages were: stage I (n=4, 8.9%); stage II (n=10, 22.2%); stage III (n=5, 11.1%); and stage IVa (n=26, 57.8%). Surgical resection was performed in all patients and 6 patients also received postoperative radiotherapy. Reconstructive surgery using free flaps was performed in 38 patients; postoperative complications occurred in 5 of these patients. The 3-year local control rate was 80%, and the 3-year over all survival rates for stage I, II, III, and IV disease were 100%, 80%, 40%, and 49.2%, respectively. Cause of death was the original disease in 23 cases and other diseases in 2 cases. The most common cause of death from the original disease was cervical lymph node metastasis.

CONCLUSION

The presence of cervical lymph node metastasis was a negative prognostic factor. Marginal mandibulectomy may be selected for patients without distinct bone-marrow infiltration.

摘要

目的

磨牙后三角区鳞状细胞癌(SCC)并不常见,在日本占所有口腔癌病例的1.4%。很少有研究探讨这种癌症的最佳治疗方法。本研究的目的是评估磨牙后区原发性SCC的治疗结果。

方法

我们回顾性分析了1992年7月至2011年3月在我科接受治疗的45例磨牙后三角区SCC患者(38例男性,7例女性)的治疗结果和预后。

结果

平均年龄为62.4岁。临床分期为:I期(n = 4,8.9%);II期(n = 10,22.2%);III期(n = 5,11.1%);IVa期(n = 26,57.8%)。所有患者均接受了手术切除,6例患者还接受了术后放疗。38例患者采用游离皮瓣进行了重建手术;其中5例患者出现了术后并发症。3年局部控制率为80%,I、II、III和IV期疾病的3年总生存率分别为100%、80%、40%和49.2%。死亡原因中,23例为原发病,2例为其他疾病。原发病最常见的死亡原因是颈部淋巴结转移。

结论

颈部淋巴结转移的存在是一个负面预后因素。对于没有明显骨髓浸润的患者,可选择下颌骨边缘切除术。

相似文献

1
Squamous cell carcinoma of the retromolar trigone: Treatment outcomes.磨牙后三角区鳞状细胞癌:治疗结果
Auris Nasus Larynx. 2018 Apr;45(2):337-342. doi: 10.1016/j.anl.2017.05.011. Epub 2017 Jun 16.
2
Treatment of squamous cell carcinoma of the anterior faucial pillar-retromolar trigone.咽前柱-磨牙后三角区鳞状细胞癌的治疗
Oral Oncol. 2003 Oct;39(7):680-6. doi: 10.1016/s1368-8375(03)00077-0.
3
Marginal and segmental mandibulectomy in patients with oral cancer: a statistical analysis of 106 cases.口腔癌患者的边缘性和节段性下颌骨切除术:106例病例的统计分析
J Oral Maxillofac Surg. 2003 Nov;61(11):1289-96. doi: 10.1016/s0278-2391(03)00730-4.
4
Prognostic factors of cervical node status in head and neck squamous cell carcinoma.头颈部鳞状细胞癌颈淋巴结状态的预后因素
World J Surg Oncol. 2015 Feb 15;13:51. doi: 10.1186/s12957-015-0460-6.
5
Cancer of retromolar trigone: long-term radiation therapy outcome.磨牙后三角区癌:长期放射治疗结果
Head Neck. 2001 Sep;23(9):758-63. doi: 10.1002/hed.1108.
6
Endoscopic-assisted selective neck dissection via small lateral neck incision for early-stage (T1-2N0M0) head and neck squamous cell carcinoma: 3-year follow-up results.经颈部小切口内镜辅助选择性颈清扫术治疗早期(T1-2N0M0)头颈部鳞状细胞癌:3年随访结果
Surg Endosc. 2017 Feb;31(2):894-900. doi: 10.1007/s00464-016-5051-2. Epub 2016 Jul 1.
7
'Doing as little as possible and as much as necessary' - Oncological efficacy of marginal mandibulectomy in resection of oral cavity cancers.“尽可能少做,尽可能多做必要的”——边缘下颌骨切除术在口腔癌切除中的肿瘤学疗效。
Oral Oncol. 2019 Aug;95:91-94. doi: 10.1016/j.oraloncology.2019.05.026. Epub 2019 Jun 11.
8
Assessment of quality of life in patients with advanced oral cancer who underwent mandibulectomy with or without bone reconstruction.对接受或未接受骨重建的下颌骨切除术的晚期口腔癌患者的生活质量评估。
Rev Assoc Med Bras (1992). 2018 Aug;64(8):710-716. doi: 10.1590/1806-9282.64.08.710.
9
Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients.口腔鳞状细胞癌对侧颈部淋巴结转移:一项对315例患者的回顾性分析研究
J Oral Maxillofac Surg. 2008 Jul;66(7):1390-8. doi: 10.1016/j.joms.2008.01.012.
10
Retromolar trigone--oropharynx junction maligns tumor surgery: transmandibular versus oral approach.磨牙后三角区-口咽交界处恶性肿瘤手术:经下颌骨入路与经口入路
Rev Med Chir Soc Med Nat Iasi. 2015 Jan-Mar;119(1):119-26.

引用本文的文献

1
A systematic review of therapeutic outcomes following treatment of squamous cell carcinoma of the retromolar trigone.对磨牙后三角区鳞状细胞癌治疗后治疗结果的系统评价。
J Korean Assoc Oral Maxillofac Surg. 2021 Aug 31;47(4):291-314. doi: 10.5125/jkaoms.2021.47.4.291.
2
Postoperative Concurrent Chemoradiotherapy Radiotherapy Alone for Advanced Oral Cavity Cancer in the Era of Modern Radiation Techniques.现代放疗技术时代晚期口腔癌术后同步放化疗与单纯放疗的比较
Front Oncol. 2021 Mar 12;11:619372. doi: 10.3389/fonc.2021.619372. eCollection 2021.
3
Treatment Outcomes for Primary Retromolar Trigone Carcinoma: A Single Institution Experience.
原发性磨牙后三角区癌的治疗结果:单机构经验
Turk Arch Otorhinolaryngol. 2020 Jun;58(2):87-92. doi: 10.5152/tao.2020.5153. Epub 2020 Jun 1.
4
Survival outcomes after treatment of cancer of the oral cavity (1985-2015).口腔癌治疗后的生存结果(1985-2015 年)。
Oral Oncol. 2019 Mar;90:115-121. doi: 10.1016/j.oraloncology.2019.02.001. Epub 2019 Feb 15.